Johnson BE - Search Results

1

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.

Jänne PA, Li C, Zhao X, Girard L, Chen TH, Minna J, Christiani DC, Johnson BE, Meyerson M. Jänne PA, et al. Among authors: johnson be. Oncogene. 2004 Apr 8;23(15):2716-26. doi: 10.1038/sj.onc.1207329. Oncogene. 2004. PMID: 15048096

2

High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors.

D'Amico D, Carbone D, Mitsudomi T, Nau M, Fedorko J, Russell E, Johnson B, Buchhagen D, Bodner S, Phelps R, et al. D'Amico D, et al. Oncogene. 1992 Feb;7(2):339-46. Oncogene. 1992. PMID: 1312696

3

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.

Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP. Winter SF, et al. Among authors: johnson be. Cancer Res. 1992 Aug 1;52(15):4168-74. Cancer Res. 1992. PMID: 1322237

4

myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.

Johnson BE, Brennan JF, Ihde DC, Gazdar AF. Johnson BE, et al. J Natl Cancer Inst Monogr. 1992;(13):39-43. J Natl Cancer Inst Monogr. 1992. PMID: 1327035

5

Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer.

D'Amico D, Carbone DP, Johnson BE, Meltzer SJ, Minna JD. D'Amico D, et al. Among authors: johnson be. Cancer Res. 1992 Apr 1;52(7):1996-9. Cancer Res. 1992. PMID: 1348017

6

Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial.

Gazdar AF, Steinberg SM, Russell EK, Linnoila RI, Oie HK, Ghosh BC, Cotelingam JD, Johnson BE, Minna JD, Ihde DC. Gazdar AF, et al. Among authors: johnson be. J Natl Cancer Inst. 1990 Jan 17;82(2):117-24. doi: 10.1093/jnci/82.2.117. J Natl Cancer Inst. 1990. PMID: 2152944 Clinical Trial.

7

Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.

Johnson BE, Grayson J, Makuch RW, Linnoila RI, Anderson MJ, Cohen MH, Glatstein E, Minna JD, Ihde DC. Johnson BE, et al. J Clin Oncol. 1990 Mar;8(3):396-401. doi: 10.1200/JCO.1990.8.3.396. J Clin Oncol. 1990. PMID: 2155310

8

Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung.

Brauch H, Johnson B, Hovis J, Yano T, Gazdar A, Pettengill OS, Graziano S, Sorenson GD, Poiesz BJ, Minna J, et al. Brauch H, et al. N Engl J Med. 1987 Oct 29;317(18):1109-13. doi: 10.1056/NEJM198710293171803. N Engl J Med. 1987. PMID: 2821398

9

Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.

Naylor SL, Johnson BE, Minna JD, Sakaguchi AY. Naylor SL, et al. Among authors: johnson be. Nature. 1987 Oct 1-7;329(6138):451-4. doi: 10.1038/329451a0. Nature. 1987. PMID: 2821400

10

Chemosensitivity testing of human lung cancer cell lines using the MTT assay.

Carmichael J, Mitchell JB, DeGraff WG, Gamson J, Gazdar AF, Johnson BE, Glatstein E, Minna JD. Carmichael J, et al. Among authors: johnson be. Br J Cancer. 1988 Jun;57(6):540-7. doi: 10.1038/bjc.1988.125. Br J Cancer. 1988. PMID: 2841961 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters